Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Product Recall and Market Withdrawal

Posted on By

Standard Operating Procedure for Product Recall and Market Withdrawal

Purpose

The purpose of this SOP is to establish procedures for the prompt and effective recall or market withdrawal of pharmaceutical products in the event of quality issues or safety concerns, in compliance with Good Distribution Practice (GDP) guidelines.

Scope

This SOP applies to all personnel involved in the distribution, quality control, and regulatory affairs departments responsible for managing product recalls or market withdrawals.

Responsibilities

  • The Quality Assurance (QA) Department is responsible for initiating and coordinating product recalls or market withdrawals.
  • The Regulatory Affairs Department is responsible for communicating with regulatory authorities and stakeholders regarding recall or withdrawal actions.
  • The Distribution Department is responsible for executing recall or withdrawal activities and maintaining records.
See also  SOP for Handling of Product Recalls

Procedure

  1. Identification of Recall or Withdrawal Trigger:
    • Any employee who becomes aware of a potential quality issue or safety concern with a product must immediately report it to the QA Department.
  2. Evaluation and Classification:
    • The QA Department assesses the severity of the issue and determines whether a recall or market withdrawal is necessary.
    • Recalls are classified based on the level of risk to public health (e.g., Class I for serious risk, Class II for temporary or reversible effects, Class III for minor issues).
  3. Recall Strategy Development:
    • Develop a recall strategy, including communication plans, recall
scope, and target markets.
  • Assign responsibilities and establish a recall team to manage the process.
  • Notification to Regulatory Authorities:
    • Notify relevant regulatory authorities promptly according to regulatory requirements.
    • Provide detailed information about the product, reason for recall, and proposed actions.
  • Communication with Stakeholders:
    • Inform customers, distributors, and other stakeholders affected by the recall or withdrawal.
    • Provide clear instructions on how to return or dispose of the affected products.
  • Execution of Recall or Withdrawal:
    • Coordinate the retrieval, quarantine, and disposal of affected products in collaboration with the Distribution Department.
    • Monitor the progress of the recall and ensure timely completion.
  • Documentation and Reporting:
    • Maintain detailed records of all recall activities, including communication logs, product disposition, and regulatory correspondence.
    • Prepare and submit final recall reports to regulatory authorities as required.
  • Abbreviations

    • QA – Quality Assurance
    • GDP – Good Distribution Practice

    Documents

    Reference documents related to product recall and market withdrawal may include:

    • Regulatory requirements for recall management
    • Internal procedures for recall execution
    • Communication templates
    • Recall notification logs
    • Product disposition records
    • Final recall reports

    Reference

    Good Distribution Practice Guidelines

    SOP Version

    Version 1.0

    See also  SOP for Destruction of Expired or Rejected Products
    Good Distribution Practice Tags:Cold chain management, Controlled drug handling regulations, Distribution logistics, Distribution quality control, Distribution quality management, GDP audit, GDP certification, GDP compliance, GDP guidelines, GDP regulations, GDP training, Good Distribution Practice SOPs, Good Distribution Practice training, Pharmaceutical distribution, Pharmaceutical distribution standards, Pharmaceutical logistics, Pharmaceutical supply chain, Regulatory compliance in distribution, Storage conditions monitoring, Temperature mapping, Temperature-controlled logistics, Transportation validation, Warehousing best practices

    Post navigation

    Previous Post: SOP for Management Review
    Next Post: Good Distribution Practice: SOP for Complaint Handling

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version